Truist Financial Issues Positive Forecast for BKV (NYSE:BKV) Stock Price

by · The Cerbat Gem

BKV (NYSE:BKV – Get Free Report) had its target price increased by equities research analysts at Truist Financial from $33.00 to $34.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price target would suggest a potential upside of 48.75% from the stock’s previous close.

BKV has been the subject of a number of other reports. Jefferies Financial Group reiterated a “buy” rating and issued a $34.00 price target on shares of BKV in a research note on Friday, July 10th. Raymond James Financial set a $29.00 price objective on shares of BKV in a research report on Tuesday, September 15th. Wall Street Zen upgraded shares of BKV from a “strong sell” rating to a “sell” rating in a report on Saturday, September 19th. Barclays dropped their target price on shares of BKV from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Tuesday, September 15th. Finally, Weiss Ratings raised shares of BKV from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $33.67.

Read Our Latest Analysis on BKV

BKV Stock Performance

NYSE BKV traded down $1.58 during trading hours on Wednesday, hitting $22.86. The company’s stock had a trading volume of 1,024,461 shares, compared to its average volume of 1,105,116. BKV has a 12 month low of $20.08 and a 12 month high of $32.81. The company’s 50 day simple moving average is $24.17 and its two-hundred day simple moving average is $25.99. The company has a market cap of $2.50 billion, a P/E ratio of 8.33 and a beta of 1.13. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.15 and a quick ratio of 1.10.

BKV (NYSE:BKV – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.21. The business had revenue of $465.54 million for the quarter, compared to analysts’ expectations of $355.25 million. BKV had a net margin of 17.73% and a return on equity of 6.67%. As a group, sell-side analysts expect that BKV will post 1.62 EPS for the current fiscal year.

Insider Activity at BKV

In other BKV news, SVP Javier Hinojosa sold 7,428 shares of the firm’s stock in a transaction dated Friday, September 25th. The stock was sold at an average price of $22.66, for a total value of $168,318.48. Following the transaction, the senior vice president directly owned 76,848 shares of the company’s stock, valued at approximately $1,741,375.68. This trade represents a 8.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $25.63, for a total value of $38,445.00. Following the sale, the chief financial officer owned 57,024 shares of the company’s stock, valued at approximately $1,461,525.12. This represents a 2.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 35,626 shares of company stock worth $901,589. 2.51% of the stock is owned by insiders.

Institutional Investors Weigh In On BKV

Several hedge funds and other institutional investors have recently made changes to their positions in BKV. Bank of New York Mellon Corp bought a new stake in shares of BKV during the 2nd quarter valued at $15,261,000. Value Aligned Research Advisors LLC increased its stake in shares of BKV by 110.5% in the 2nd quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company’s stock worth $18,602,000 after purchasing an additional 356,848 shares in the last quarter. William Blair Investment Management LLC bought a new position in BKV in the 2nd quarter worth $32,689,000. Moore Capital Management LP bought a new position in BKV in the 2nd quarter worth $2,001,000. Finally, SIR Capital Management L.P. bought a new position in BKV in the 2nd quarter worth $1,135,000.

BKV Company Profile

(Get Free Report)

BKV Corporation is an energy company focused on natural gas production and related energy-transition solutions. The company explores for, develops and produces natural gas and natural gas liquids, with operations primarily centered in major U.S. shale basins.

BKV’s activities include upstream oil and gas development, natural gas marketing and midstream services. The company also develops carbon capture, utilization and storage projects intended to reduce emissions associated with natural gas production and use, as well as renewable natural gas initiatives.

Based in Denver, Colorado, BKV serves U.S.

Further Reading